Liqin Lu

机构：Zhejiang Provincial People's Hospital · ORCID：0000-0001-7786-5035

发表论文 67 篇 · 总被引 1533 次 · h-index 19

代表论文

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer (2022 · JAMA · 被引 480)
Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics (2021 · Bioactive Materials · 被引 35)
Blind power spectrum reconstruction for multi-sinusoid signals with generative multicoset sampling (2024 · Signal Processing · 被引 12)
Development and assessment of the efficacy and safety of human lung-targeting liposomal methylprednisolone crosslinked with nanobody (2021 · Drug Delivery · 被引 11)
Active aliasing ESPRIT: A robust parameter estimation method for low-intervention Blade tip timing measurement (2025 · Mechanical Systems and Signal Processing · 被引 10)
Chidamide plus envafolimab as subsequent treatment in advanced non‐small cell lung cancer patients resistant to anti‐PD‐1 therapy: A multicohort, open‐label, phase II trial with biomarker analysis (2024 · Cancer Medicine · 被引 8)